Memory, Phenotype, and Function of TB-reactive Human MR1 Restricted T cells

结核病反应性人 MR1 限制性 T 细胞的记忆、表型和功能

基本信息

  • 批准号:
    10329945
  • 负责人:
  • 金额:
    $ 56.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-02-01 至 2024-01-31
  • 项目状态:
    已结题

项目摘要

Project Summary Mucosal associated invariant T (MAIT) cells, a subset of T cells restricted by MR1 (MR1T cells), are an innate- like T cell subset prevalent in humans and distributed throughout mucosal sites. Human MAIT cells are defined by the expression of the semi-invariant TCRα chain TRAV1-2/TRAJ12/20/33, restriction by the non- polymorphic major histocompatibility complex (MHC) class I-like molecule, MHC-related protein 1 (MR1), and by recognition of small organic molecules, derived from riboflavin biosynthesis. We have found that MAIT cells are both “innate” effectors as evidenced by their functionality in the thymus, and have the capacity to adapt to their environment as evidenced by their effector memory cell surface phenotype and selective TCR usage. However, it is not clear if these expansions are driven by ongoing microbial or environmental exposures, or if MAIT cells retain the capacity to respond selectively to future antigenic challenges. If MAIT cells have memory, then they could be harnessed in future vaccination strategies. We provide evidence demonstrating oligoclonal expansions of pro-inflammatory MAIT cells in the human airway of subjects infected with TB. We also provide evidence that vaccination with BCG can result in functional MAIT cell expansion, and provide evidence that MAIT cells have an anti-microbial, polycytotoxic phenotype. We postulate that MR1T cells can facilitate the control of infection with Mtb, and will explore whether or not these cells have immunologic memory. Specific Aim 1: To determine whether or not CD8+ MR1T cells have features of immunologic memory. By determining the TCR repertoire of MR1T cells prior to antigenic exposure (human cord blood mononuclear cells; CBMC), following antigenic exposure as a result of infant vaccination with BCG, in the setting of TB (adult PBMC), in the lungs (BAL) and peripheral blood of subjects with pulmonary TB at the time of diagnosis and following treatment, we will establish if MAIT cells demonstrate TCR usage that reflects antigenic exposure, persistence following antigenic exposure, and dependence on the presence of antigen. Specifically, we anticipate that we will observe a broad repertoire of MR1T cell TCRs in human cord blood, and that in adults we will observe a narrower repertoire characterized by oligocolonal expansions. Following vaccination with BCG and in TB, we would expect to observe oligoclonal expansions in the PBMC and BAL, and would predict that these cells will return to the circulation following treatment. Finally, we will ask if these TCRs are associated with discrete ligand recognition. Specific Aim 2: To define the phenotype and functional capacity of MR1T cells. A combination of flow cytometric analysis of both ex vivo MR1T cells and MR1T cell clones, expression data analysis of ex vivo MR1T cells, and mechanistic evaluation of MR1T cell clones derived from each of the cohorts and time points described will be used to define the full functional and anti-microbial phenotype of these cells.
项目总结

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Production of Proinflammatory Cytokines by CD4+ and CD8+ T Cells in Response to Mycobacterial Antigens among Children and Adults with Tuberculosis.
  • DOI:
    10.3390/pathogens12111353
  • 发表时间:
    2023-11-14
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Morrow E;Liu Q;Kiguli S;Swarbrick G;Nsereko M;Null MD;Cansler M;Mayanja-Kizza H;Boom WH;Chheng P;Nyendak MR;Lewinsohn DM;Lewinsohn DA;Lancioni CL
  • 通讯作者:
    Lancioni CL
The Missing Link in Correlates of Protective Tuberculosis Immunity: Recognizing the Infected Cell.
  • DOI:
    10.3389/fimmu.2022.869057
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
  • 通讯作者:
Optimising the yield from bronchoalveolar lavage on human participants in infectious disease immunology research.
  • DOI:
    10.1038/s41598-023-35723-2
  • 发表时间:
    2023-05-31
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
  • 通讯作者:
Postnatal Expansion, Maturation, and Functionality of MR1T Cells in Humans.
  • DOI:
    10.3389/fimmu.2020.556695
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
    Swarbrick GM;Gela A;Cansler ME;Null MD;Duncan RB;Nemes E;Shey M;Nsereko M;Mayanja-Kizza H;Kiguli S;Koh J;Hanekom WA;Hatherill M;Lancioni C;Lewinsohn DM;Scriba TJ;Lewinsohn DA
  • 通讯作者:
    Lewinsohn DA
Functional and Activation Profiles of Mucosal-Associated Invariant T Cells in Patients With Tuberculosis and HIV in a High Endemic Setting.
  • DOI:
    10.3389/fimmu.2021.648216
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
    Balfour A;Schutz C;Goliath R;Wilkinson KA;Sayed S;Sossen B;Kanyik JP;Ward A;Ndzhukule R;Gela A;Lewinsohn DM;Lewinsohn DA;Meintjes G;Shey M
  • 通讯作者:
    Shey M
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID M. LEWINSOHN其他文献

DAVID M. LEWINSOHN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID M. LEWINSOHN', 18)}}的其他基金

Lung Resident, MR1-Restricted T Cells: Association with Differential Outcomes Following Exposure to M. Tuberculosis
肺驻留、MR1 限制性 T 细胞:与接触结核分枝杆菌后不同结果的关联
  • 批准号:
    10404652
  • 财政年份:
    2018
  • 资助金额:
    $ 56.32万
  • 项目类别:
Lung Resident, MR1-Restricted T Cells: Association with Differential Outcomes Following Exposure to M. Tuberculosis
肺驻留、MR1 限制性 T 细胞:与接触结核分枝杆菌后不同结果的关联
  • 批准号:
    10164711
  • 财政年份:
    2018
  • 资助金额:
    $ 56.32万
  • 项目类别:
Lung Resident, MR1-Restricted T Cells: Association with Differential Outcomes Following Exposure to M. Tuberculosis
肺驻留、MR1 限制性 T 细胞:与接触结核分枝杆菌后不同结果的关联
  • 批准号:
    9593711
  • 财政年份:
    2018
  • 资助金额:
    $ 56.32万
  • 项目类别:
Human MAIT celis in airway mucosal immune responses to intracellular infections
人 MAIT 细胞在气道粘膜对细胞内感染的免疫反应中的作用
  • 批准号:
    8880108
  • 财政年份:
    2011
  • 资助金额:
    $ 56.32万
  • 项目类别:
Recognition of Mtb-infected Cells by CD8+ T Lymphocytes
CD8 T 淋巴细胞对 Mtb 感染细胞的识别
  • 批准号:
    8072940
  • 财政年份:
    2010
  • 资助金额:
    $ 56.32万
  • 项目类别:
Recognition of Mtb-Infected Cells by Non-Classically Restritcted CD8+ T Cells
非经典限制性 CD8 T 细胞对 Mtb 感染细胞的识别
  • 批准号:
    8195873
  • 财政年份:
    2010
  • 资助金额:
    $ 56.32万
  • 项目类别:
Recognition of Mtb-Infected Cells by Non-Classically Restritcted CD8+ T Cells
非经典限制性 CD8 T 细胞对 Mtb 感染细胞的识别
  • 批准号:
    7931814
  • 财政年份:
    2010
  • 资助金额:
    $ 56.32万
  • 项目类别:
Recognition of Mtb-Infected Cells by Non-Classically Restritcted CD8+ T Cells
非经典限制性 CD8 T 细胞对 Mtb 感染细胞的识别
  • 批准号:
    8397519
  • 财政年份:
    2010
  • 资助金额:
    $ 56.32万
  • 项目类别:
Recognition of Mtb-Infected Cells by Non-Classically Restricted CD8+ T Cells
非经典限制性 CD8 T 细胞对 Mtb 感染细胞的识别
  • 批准号:
    10554259
  • 财政年份:
    2010
  • 资助金额:
    $ 56.32万
  • 项目类别:
Recognition of Mtb-infected Cells by CD8+ T Lymphocytes
CD8 T 淋巴细胞对 Mtb 感染细胞的识别
  • 批准号:
    8112146
  • 财政年份:
    2010
  • 资助金额:
    $ 56.32万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 56.32万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 56.32万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.32万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.32万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 56.32万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.32万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 56.32万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 56.32万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 56.32万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.32万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了